Krystal Biotech, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC KRYS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

33,617

Value ($000)

8,288

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	8,288	0.0%	33,617	12/31/2025
2025 Q3	11/14/2025	35,763	0.0%	202,589	9/30/2025
2025 Q2	8/14/2025	32,210	0.0%	234,320	6/30/2025
2025 Q1	5/19/2025	103,764	0.0%	575,506	3/31/2025
2024 Q4	2/14/2025	32,930	0.0%	210,202	12/31/2024
2024 Q3	11/14/2024	40,947	0.0%	224,945	9/30/2024
2024 Q2	8/14/2024	46,234	0.0%	251,762	6/30/2024
2024 Q1	5/15/2024	3,249	0.0%	18,261	3/31/2024
2023 Q4	2/14/2024	2,534	0.0%	20,426	12/31/2023
2023 Q3	11/13/2023	2,369	0.0%	20,426	9/30/2023
2023 Q2	8/11/2023	1,344	0.0%	16,793	6/30/2023
2023 Q1	5/15/2023	1,344	0.0%	16,793	3/31/2023
2022 Q4	2/14/2023	1,226	0.0%	15,471	12/31/2022
2022 Q3	11/14/2022	1,127	0.0%	16,172	9/30/2022
2022 Q2	8/12/2022	998	0.0%	15,207	6/30/2022
2022 Q1	5/16/2022	1,012	0.0%	15,207	3/31/2022
2021 Q4	2/14/2022	713	0.0%	10,193	12/31/2021
2021 Q3	11/15/2021	454	0.0%	8,705	9/30/2021
2021 Q2	8/16/2021	592	0.0%	8,705	6/30/2021
2021 Q1	5/14/2021	722	0.0%	9,367	3/31/2021
2020 Q4	3/1/2021	640	0.0%	10,667	12/31/2020
2020 Q3	11/13/2020	459	0.0%	10,667	9/30/2020
2020 Q2	8/14/2020	224	0.0%	5,400	6/30/2020
2020 Q1	5/15/2020	254	0.0%	5,867	3/31/2020
2019 Q4	2/14/2020	227	0.0%	4,100	12/31/2019